Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| 1 |
AstraZeneca
AZN
|
+$810M |
| 2 |
Intuitive Surgical
ISRG
|
+$705M |
| 3 |
S&P Global
SPGI
|
+$439M |
| 4 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
+$361M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$253M |
Top Sells
| 1 |
Broadcom
AVGO
|
+$605M |
| 2 |
FedEx
FDX
|
+$587M |
| 3 |
Monster Beverage
MNST
|
+$395M |
| 4 |
McDonald's
MCD
|
+$387M |
| 5 |
Booking.com
BKNG
|
+$380M |
Sector Composition
| 1 | Technology | 22.3% |
| 2 | Consumer Discretionary | 16.25% |
| 3 | Healthcare | 15.51% |
| 4 | Financials | 12.99% |
| 5 | Communication Services | 11.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
401
Honeywell
HON
$135B
| $19.2M | 0.02% |
120,580
+53,163
| +79% | +$8.48M |
|
402
Owens Corning
OC
$13B
| $19.2M | 0.02% |
353,941
-5,874
| -2% | -$319K |
|
|
MRNS
403
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $19M | 0.02% |
475,631
-213,708
| -31% | -$8.55M |
|
|
XOG
404
DELISTED
Extraction Oil & Gas, Inc. Common Stock
XOG
| $18.8M | 0.02% |
+1,662,450
| New | +$18.8M |
|
|
AXE
405
DELISTED
Anixter International Inc
AXE
| $18.5M | 0.02% |
263,497
-353,922
| -57% | -$24.9M |
|
406
Independence Realty Trust
IRT
$4.12B
| $18.4M | 0.02% |
1,749,949
-29,077
| -2% | -$306K |
|
|
GOLD
407
DELISTED
Randgold Resources Ltd
GOLD
| $18.4M | 0.02% |
260,298
-17,977
| -6% | -$1.27M |
|
408
Healthcare Services Group
HCSG
$1.18B
| $18.3M | 0.02% |
450,899
+155,495
| +53% | +$6.32M |
|
|
ABMD
409
DELISTED
Abiomed Inc
ABMD
| $18.3M | 0.02% |
+40,682
| New | +$18.3M |
|
410
B&G Foods
BGS
$364M
| $18.2M | 0.02% |
664,578
-464
| -0.1% | -$12.7K |
|
411
Monro
MNRO
$526M
| $18.1M | 0.02% |
260,279
+10
| +0% | +$696 |
|
412
Philip Morris
PM
$264B
| $17.4M | 0.02% |
+213,945
| New | +$17.4M |
|
|
PXD
413
DELISTED
Pioneer Natural Resource Co.
PXD
| $17.4M | 0.02% |
99,974
-7,078
| -7% | -$1.23M |
|
|
BPMC
414
DELISTED
Blueprint Medicines
BPMC
| $17.4M | 0.02% |
222,540
+1,658
| +0.8% | +$129K |
|
|
QTS
415
DELISTED
QTS REALTY TRUST, INC.
QTS
| $17.3M | 0.02% |
405,339
-7
| -0% | -$299 |
|
416
Huron Consulting
HURN
$2.41B
| $17.2M | 0.02% |
347,400
+4,683
| +1% | +$231K |
|
|
FOCS
417
DELISTED
Focus Financial Partners Inc. Class A
FOCS
| $17.1M | 0.02% |
+360,868
| New | +$17.1M |
|
418
Newmont
NEM
$86.2B
| $17.1M | 0.02% |
564,663
-39,523
| -7% | -$1.19M |
|
419
Tenaris
TS
$18.7B
| $17M | 0.02% |
507,211
+50,151
| +11% | +$1.68M |
|
420
Core Laboratories
CLB
$597M
| $16.9M | 0.02% |
145,795
-10,739
| -7% | -$1.24M |
|
421
Vodafone
VOD
$28.5B
| $16.7M | 0.02% |
770,399
-2,134,554
| -73% | -$46.3M |
|
422
Acadia Healthcare
ACHC
$2.02B
| $16.7M | 0.02% |
473,392
+95,946
| +25% | +$3.38M |
|
423
Ocular Therapeutix
OCUL
$2.22B
| $16.1M | 0.01% |
2,335,989
+16,734
| +0.7% | +$115K |
|
424
KLX Energy Services
KLXE
$33.5M
| $15.9M | 0.01% |
+99,593
| New | +$15.9M |
|
|
NUVA
425
DELISTED
NuVasive, Inc.
NUVA
| $15.8M | 0.01% |
223,239
+4
| +0% | +$284 |
|